APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Cough and Cold and Allergy Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global OTC Cough and Cold and Allergy Medicine Market Outlook and Growth Opportunities 2026

20 December 2025196 pages

Choose your research edition.

Industry ResearchOTC Cough and Cold and Allergy Medicine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Cough and Cold and Allergy Medicine Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal OTC Cough and Cold and Allergy Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Cough and Cold and Allergy Medicine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Cough and Cold and Allergy Medicine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global OTC Cough and Cold and Allergy Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for OTC Cough and Cold and Allergy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Cough and Cold and Allergy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Cough and Cold and Allergy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the OTC Cough and Cold and Allergy Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the OTC Cough and Cold and Allergy Medicine market include Allergen, AstraZaneca, Bristol-Myers Squib, Prestige Brands Holdings, Procter and Gamble, Reckitt Benckiser Group, Sanofi-Aventis, GlaxoSmithKline and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global OTC Cough and Cold and Allergy Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Cough and Cold and Allergy Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Cough and Cold and Allergy Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the OTC Cough and Cold and Allergy Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

OTC Cough and Cold and Allergy Medicine Segment by Company

Allergen

AstraZaneca

Bristol-Myers Squib

Prestige Brands Holdings

Procter and Gamble

Reckitt Benckiser Group

Sanofi-Aventis

GlaxoSmithKline

Pfizer

Merck and Co.

Novartis

Johnson and Johnson

Sun Pharmaceutical Industries

OTC Cough and Cold and Allergy Medicine Segment by Type

Antibiotics

Antihistamine

Expectorants

Bronchodialators

Others

OTC Cough and Cold and Allergy Medicine Segment by Application

Online

Offline

OTC Cough and Cold and Allergy Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global OTC Cough and Cold and Allergy Medicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions OTC Cough and Cold and Allergy Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify OTC Cough and Cold and Allergy Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze OTC Cough and Cold and Allergy Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Cough and Cold and Allergy Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Cough and Cold and Allergy Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Cough and Cold and Allergy Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the OTC Cough and Cold and Allergy Medicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Cough and Cold and Allergy Medicine industry.

Chapter 3: Detailed analysis of OTC Cough and Cold and Allergy Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of OTC Cough and Cold and Allergy Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of OTC Cough and Cold and Allergy Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. OTC Cough and Cold and Allergy Medicine Industry Trends Table 2. OTC Cough and Cold and Allergy Medicine Industry Drivers Table 3. OTC Cough and Cold and Allergy Medicine Industry Opportunities and Challenges Table 4. OTC Cough and Cold and Allergy Medicine Industry Restraints Table 5. Global OTC Cough and Cold and Allergy Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global OTC Cough and Cold and Allergy Medicine Revenue Share by Company (2021-2026) Table 7. Global OTC Cough and Cold and Allergy Medicine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global OTC Cough and Cold and Allergy Medicine Sales Volume Share by Company (2021-2026) Table 9. Global OTC Cough and Cold and Allergy Medicine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global OTC Cough and Cold and Allergy Medicine Company Ranking, (2024-2026) & (USD Million) Table 11. Global OTC Cough and Cold and Allergy Medicine Key Company Manufacturing Base & Headquarters Table 12. Global OTC Cough and Cold and Allergy Medicine Company, Product Type & Application Table 13. Global OTC Cough and Cold and Allergy Medicine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global OTC Cough and Cold and Allergy Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Antibiotics Table 18. Significant Companies of Antihistamine Table 19. Significant Companies of Expectorants Table 20. Significant Companies of Bronchodialators Table 21. Significant Companies of Others Table 22. Global OTC Cough and Cold and Allergy Medicine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global OTC Cough and Cold and Allergy Medicine Sales Volume by Type (2021-2026) & (K Units) Table 24. Global OTC Cough and Cold and Allergy Medicine Sales Volume by Type (2027-2032) & (K Units) Table 25. Global OTC Cough and Cold and Allergy Medicine Sales Volume Share by Type (2021-2026) Table 26. Global OTC Cough and Cold and Allergy Medicine Sales Volume Share by Type (2027-2032) Table 27. Global OTC Cough and Cold and Allergy Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global OTC Cough and Cold and Allergy Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global OTC Cough and Cold and Allergy Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global OTC Cough and Cold and Allergy Medicine Sales Value Share by Type (2021-2026) Table 31. Global OTC Cough and Cold and Allergy Medicine Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Online Table 33. Significant Companies of Offline Table 34. Global OTC Cough and Cold and Allergy Medicine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global OTC Cough and Cold and Allergy Medicine Sales Volume by Application (2021-2026) & (K Units) Table 36. Global OTC Cough and Cold and Allergy Medicine Sales Volume by Application (2027-2032) & (K Units) Table 37. Global OTC Cough and Cold and Allergy Medicine Sales Volume Share by Application (2021-2026) Table 38. Global OTC Cough and Cold and Allergy Medicine Sales Volume Share by Application (2027-2032) Table 39. Global OTC Cough and Cold and Allergy Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global OTC Cough and Cold and Allergy Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global OTC Cough and Cold and Allergy Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global OTC Cough and Cold and Allergy Medicine Sales Value Share by Application (2021-2026) Table 43. Global OTC Cough and Cold and Allergy Medicine Sales Value Share by Application (2027-2032) Table 44. Global OTC Cough and Cold and Allergy Medicine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global OTC Cough and Cold and Allergy Medicine Sales by Region (2021-2026) & (K Units) Table 46. Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Region (2021-2026) Table 47. Global OTC Cough and Cold and Allergy Medicine Sales by Region (2027-2032) & (K Units) Table 48. Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Region (2027-2032) Table 49. Global OTC Cough and Cold and Allergy Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global OTC Cough and Cold and Allergy Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global OTC Cough and Cold and Allergy Medicine Sales Value Share by Region (2021-2026) Table 52. Global OTC Cough and Cold and Allergy Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global OTC Cough and Cold and Allergy Medicine Sales Value Share by Region (2027-2032) Table 54. Global OTC Cough and Cold and Allergy Medicine Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global OTC Cough and Cold and Allergy Medicine Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global OTC Cough and Cold and Allergy Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global OTC Cough and Cold and Allergy Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2026) & (K Units) Table 59. Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Country (2021-2026) Table 60. Global OTC Cough and Cold and Allergy Medicine Sales by Country (2027-2032) & (K Units) Table 61. Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Country (2027-2032) Table 62. Global OTC Cough and Cold and Allergy Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global OTC Cough and Cold and Allergy Medicine Sales Value Market Share by Country (2021-2026) Table 64. Global OTC Cough and Cold and Allergy Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global OTC Cough and Cold and Allergy Medicine Sales Value Market Share by Country (2027-2032) Table 66. Allergen Company Information Table 67. Allergen Business Overview Table 68. Allergen OTC Cough and Cold and Allergy Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Allergen OTC Cough and Cold and Allergy Medicine Product Portfolio Table 70. Allergen Recent Development Table 71. AstraZaneca Company Information Table 72. AstraZaneca Business Overview Table 73. AstraZaneca OTC Cough and Cold and Allergy Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AstraZaneca OTC Cough and Cold and Allergy Medicine Product Portfolio Table 75. AstraZaneca Recent Development Table 76. Bristol-Myers Squib Company Information Table 77. Bristol-Myers Squib Business Overview Table 78. Bristol-Myers Squib OTC Cough and Cold and Allergy Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bristol-Myers Squib OTC Cough and Cold and Allergy Medicine Product Portfolio Table 80. Bristol-Myers Squib Recent Development Table 81. Prestige Brands Holdings Company Information Table 82. Prestige Brands Holdings Business Overview Table 83. Prestige Brands Holdings OTC Cough and Cold and Allergy Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Prestige Brands Holdings OTC Cough and Cold and Allergy Medicine Product Portfolio Table 85. Prestige Brands Holdings Recent Development Table 86. Procter and Gamble Company Information Table 87. Procter and Gamble Business Overview Table 88. Procter and Gamble OTC Cough and Cold and Allergy Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Procter and Gamble OTC Cough and Cold and Allergy Medicine Product Portfolio Table 90. Procter and Gamble Recent Development Table 91. Reckitt Benckiser Group Company Information Table 92. Reckitt Benckiser Group Business Overview Table 93. Reckitt Benckiser Group OTC Cough and Cold and Allergy Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Reckitt Benckiser Group OTC Cough and Cold and Allergy Medicine Product Portfolio Table 95. Reckitt Benckiser Group Recent Development Table 96. Sanofi-Aventis Company Information Table 97. Sanofi-Aventis Business Overview Table 98. Sanofi-Aventis OTC Cough and Cold and Allergy Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sanofi-Aventis OTC Cough and Cold and Allergy Medicine Product Portfolio Table 100. Sanofi-Aventis Recent Development Table 101. GlaxoSmithKline Company Information Table 102. GlaxoSmithKline Business Overview Table 103. GlaxoSmithKline OTC Cough and Cold and Allergy Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. GlaxoSmithKline OTC Cough and Cold and Allergy Medicine Product Portfolio Table 105. GlaxoSmithKline Recent Development Table 106. Pfizer Company Information Table 107. Pfizer Business Overview Table 108. Pfizer OTC Cough and Cold and Allergy Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Pfizer OTC Cough and Cold and Allergy Medicine Product Portfolio Table 110. Pfizer Recent Development Table 111. Merck and Co. Company Information Table 112. Merck and Co. Business Overview Table 113. Merck and Co. OTC Cough and Cold and Allergy Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Merck and Co. OTC Cough and Cold and Allergy Medicine Product Portfolio Table 115. Merck and Co. Recent Development Table 116. Novartis Company Information Table 117. Novartis Business Overview Table 118. Novartis OTC Cough and Cold and Allergy Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Novartis OTC Cough and Cold and Allergy Medicine Product Portfolio Table 120. Novartis Recent Development Table 121. Johnson and Johnson Company Information Table 122. Johnson and Johnson Business Overview Table 123. Johnson and Johnson OTC Cough and Cold and Allergy Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Johnson and Johnson OTC Cough and Cold and Allergy Medicine Product Portfolio Table 125. Johnson and Johnson Recent Development Table 126. Sun Pharmaceutical Industries Company Information Table 127. Sun Pharmaceutical Industries Business Overview Table 128. Sun Pharmaceutical Industries OTC Cough and Cold and Allergy Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Sun Pharmaceutical Industries OTC Cough and Cold and Allergy Medicine Product Portfolio Table 130. Sun Pharmaceutical Industries Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. OTC Cough and Cold and Allergy Medicine Distributors List Table 134. OTC Cough and Cold and Allergy Medicine Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. OTC Cough and Cold and Allergy Medicine Product Image Figure 2. Global OTC Cough and Cold and Allergy Medicine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Cough and Cold and Allergy Medicine Sales Value (2021-2032) & (US$ Million) Figure 4. Global OTC Cough and Cold and Allergy Medicine Sales (2021-2032) & (K Units) Figure 5. Global OTC Cough and Cold and Allergy Medicine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global OTC Cough and Cold and Allergy Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Antibiotics Image Figure 10. Antihistamine Image Figure 11. Expectorants Image Figure 12. Bronchodialators Image Figure 13. Others Image Figure 14. Global OTC Cough and Cold and Allergy Medicine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global OTC Cough and Cold and Allergy Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global OTC Cough and Cold and Allergy Medicine Sales Volume Share by Type (2021-2032) Figure 17. Global OTC Cough and Cold and Allergy Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global OTC Cough and Cold and Allergy Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global OTC Cough and Cold and Allergy Medicine Sales Value Share by Type (2021-2032) Figure 20. Online Image Figure 21. Offline Image Figure 22. Global OTC Cough and Cold and Allergy Medicine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global OTC Cough and Cold and Allergy Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global OTC Cough and Cold and Allergy Medicine Sales Volume Share by Application (2021-2032) Figure 25. Global OTC Cough and Cold and Allergy Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global OTC Cough and Cold and Allergy Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global OTC Cough and Cold and Allergy Medicine Sales Value Share by Application (2021-2032) Figure 28. Global OTC Cough and Cold and Allergy Medicine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global OTC Cough and Cold and Allergy Medicine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global OTC Cough and Cold and Allergy Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global OTC Cough and Cold and Allergy Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America OTC Cough and Cold and Allergy Medicine Sales Value (2021-2032) & (US$ Million) Figure 33. North America OTC Cough and Cold and Allergy Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe OTC Cough and Cold and Allergy Medicine Sales Value (2021-2032) & (US$ Million) Figure 35. Europe OTC Cough and Cold and Allergy Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific OTC Cough and Cold and Allergy Medicine Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific OTC Cough and Cold and Allergy Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America OTC Cough and Cold and Allergy Medicine Sales Value (2021-2032) & (US$ Million) Figure 39. South America OTC Cough and Cold and Allergy Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa OTC Cough and Cold and Allergy Medicine Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa OTC Cough and Cold and Allergy Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. OTC Cough and Cold and Allergy Medicine Value Chain Figure 127. Manufacturing Cost Structure Figure 128. OTC Cough and Cold and Allergy Medicine Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Antibiotics
  • Antihistamine
  • Expectorants
  • Bronchodialators
  • Others
Applications
  • Online
  • Offline
Companies covered
  • Allergen
  • AstraZaneca
  • Bristol-Myers Squib
  • Prestige Brands Holdings
  • Procter and Gamble
  • Reckitt Benckiser Group
  • Sanofi-Aventis
  • GlaxoSmithKline
  • Pfizer
  • Merck and Co.
  • Novartis
  • Johnson and Johnson
  • Sun Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global OTC Cough and Cold and Allergy Medicine Sales Value (2021-2032)
  4. 1.2.2 Global OTC Cough and Cold and Allergy Medicine Sales Volume (2021-2032)
  5. 1.2.3 Global OTC Cough and Cold and Allergy Medicine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 OTC Cough and Cold and Allergy Medicine Market Dynamics
  1. 2.1 OTC Cough and Cold and Allergy Medicine Industry Trends
  2. 2.2 OTC Cough and Cold and Allergy Medicine Industry Drivers
  3. 2.3 OTC Cough and Cold and Allergy Medicine Industry Opportunities and Challenges
  4. 2.4 OTC Cough and Cold and Allergy Medicine Industry Restraints
3 OTC Cough and Cold and Allergy Medicine Market by Company
  1. 3.1 Global OTC Cough and Cold and Allergy Medicine Company Revenue Ranking in 2025
  2. 3.2 Global OTC Cough and Cold and Allergy Medicine Revenue by Company (2021-2026)
  3. 3.3 Global OTC Cough and Cold and Allergy Medicine Sales Volume by Company (2021-2026)
  4. 3.4 Global OTC Cough and Cold and Allergy Medicine Average Price by Company (2021-2026)
  5. 3.5 Global OTC Cough and Cold and Allergy Medicine Company Ranking (2024-2026)
  6. 3.6 Global OTC Cough and Cold and Allergy Medicine Company Manufacturing Base and Headquarters
  7. 3.7 Global OTC Cough and Cold and Allergy Medicine Company Product Type and Application
  8. 3.8 Global OTC Cough and Cold and Allergy Medicine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global OTC Cough and Cold and Allergy Medicine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 OTC Cough and Cold and Allergy Medicine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 OTC Cough and Cold and Allergy Medicine Market by Type
  1. 4.1 OTC Cough and Cold and Allergy Medicine Type Introduction
  2. 4.1.1 Antibiotics
  3. 4.1.2 Antihistamine
  4. 4.1.3 Expectorants
  5. 4.1.4 Bronchodialators
  6. 4.1.5 Others
  7. 4.2 Global OTC Cough and Cold and Allergy Medicine Sales Volume by Type
  8. 4.2.1 Global OTC Cough and Cold and Allergy Medicine Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global OTC Cough and Cold and Allergy Medicine Sales Volume by Type (2021-2032)
  10. 4.2.3 Global OTC Cough and Cold and Allergy Medicine Sales Volume Share by Type (2021-2032)
  11. 4.3 Global OTC Cough and Cold and Allergy Medicine Sales Value by Type
  12. 4.3.1 Global OTC Cough and Cold and Allergy Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global OTC Cough and Cold and Allergy Medicine Sales Value by Type (2021-2032)
  14. 4.3.3 Global OTC Cough and Cold and Allergy Medicine Sales Value Share by Type (2021-2032)
5 OTC Cough and Cold and Allergy Medicine Market by Application
  1. 5.1 OTC Cough and Cold and Allergy Medicine Application Introduction
  2. 5.1.1 Online
  3. 5.1.2 Offline
  4. 5.2 Global OTC Cough and Cold and Allergy Medicine Sales Volume by Application
  5. 5.2.1 Global OTC Cough and Cold and Allergy Medicine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global OTC Cough and Cold and Allergy Medicine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global OTC Cough and Cold and Allergy Medicine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global OTC Cough and Cold and Allergy Medicine Sales Value by Application
  9. 5.3.1 Global OTC Cough and Cold and Allergy Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global OTC Cough and Cold and Allergy Medicine Sales Value by Application (2021-2032)
  11. 5.3.3 Global OTC Cough and Cold and Allergy Medicine Sales Value Share by Application (2021-2032)
6 OTC Cough and Cold and Allergy Medicine Regional Sales and Value Analysis
  1. 6.1 Global OTC Cough and Cold and Allergy Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global OTC Cough and Cold and Allergy Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global OTC Cough and Cold and Allergy Medicine Sales by Region: 2021-2026
  4. 6.2.2 Global OTC Cough and Cold and Allergy Medicine Sales by Region (2027-2032)
  5. 6.3 Global OTC Cough and Cold and Allergy Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global OTC Cough and Cold and Allergy Medicine Sales Value by Region (2021-2032)
  7. 6.4.1 Global OTC Cough and Cold and Allergy Medicine Sales Value by Region: 2021-2026
  8. 6.4.2 Global OTC Cough and Cold and Allergy Medicine Sales Value by Region (2027-2032)
  9. 6.5 Global OTC Cough and Cold and Allergy Medicine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America OTC Cough and Cold and Allergy Medicine Sales Value (2021-2032)
  12. 6.6.2 North America OTC Cough and Cold and Allergy Medicine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe OTC Cough and Cold and Allergy Medicine Sales Value (2021-2032)
  15. 6.7.2 Europe OTC Cough and Cold and Allergy Medicine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific OTC Cough and Cold and Allergy Medicine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific OTC Cough and Cold and Allergy Medicine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America OTC Cough and Cold and Allergy Medicine Sales Value (2021-2032)
  21. 6.9.2 South America OTC Cough and Cold and Allergy Medicine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa OTC Cough and Cold and Allergy Medicine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa OTC Cough and Cold and Allergy Medicine Sales Value Share by Country, 2025 VS 2032
7 OTC Cough and Cold and Allergy Medicine Country-level Sales and Value Analysis
  1. 7.1 Global OTC Cough and Cold and Allergy Medicine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global OTC Cough and Cold and Allergy Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2032)
  4. 7.3.1 Global OTC Cough and Cold and Allergy Medicine Sales by Country (2021-2026)
  5. 7.3.2 Global OTC Cough and Cold and Allergy Medicine Sales by Country (2027-2032)
  6. 7.4 Global OTC Cough and Cold and Allergy Medicine Sales Value by Country (2021-2032)
  7. 7.4.1 Global OTC Cough and Cold and Allergy Medicine Sales Value by Country (2021-2026)
  8. 7.4.2 Global OTC Cough and Cold and Allergy Medicine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt OTC Cough and Cold and Allergy Medicine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt OTC Cough and Cold and Allergy Medicine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt OTC Cough and Cold and Allergy Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Allergen
  2. 8.1.1 Allergen Company Information
  3. 8.1.2 Allergen Business Overview
  4. 8.1.3 Allergen OTC Cough and Cold and Allergy Medicine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Allergen OTC Cough and Cold and Allergy Medicine Product Portfolio
  6. 8.1.5 Allergen Recent Developments
  7. 8.2 AstraZaneca
  8. 8.2.1 AstraZaneca Company Information
  9. 8.2.2 AstraZaneca Business Overview
  10. 8.2.3 AstraZaneca OTC Cough and Cold and Allergy Medicine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 AstraZaneca OTC Cough and Cold and Allergy Medicine Product Portfolio
  12. 8.2.5 AstraZaneca Recent Developments
  13. 8.3 Bristol-Myers Squib
  14. 8.3.1 Bristol-Myers Squib Company Information
  15. 8.3.2 Bristol-Myers Squib Business Overview
  16. 8.3.3 Bristol-Myers Squib OTC Cough and Cold and Allergy Medicine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bristol-Myers Squib OTC Cough and Cold and Allergy Medicine Product Portfolio
  18. 8.3.5 Bristol-Myers Squib Recent Developments
  19. 8.4 Prestige Brands Holdings
  20. 8.4.1 Prestige Brands Holdings Company Information
  21. 8.4.2 Prestige Brands Holdings Business Overview
  22. 8.4.3 Prestige Brands Holdings OTC Cough and Cold and Allergy Medicine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Prestige Brands Holdings OTC Cough and Cold and Allergy Medicine Product Portfolio
  24. 8.4.5 Prestige Brands Holdings Recent Developments
  25. 8.5 Procter and Gamble
  26. 8.5.1 Procter and Gamble Company Information
  27. 8.5.2 Procter and Gamble Business Overview
  28. 8.5.3 Procter and Gamble OTC Cough and Cold and Allergy Medicine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Procter and Gamble OTC Cough and Cold and Allergy Medicine Product Portfolio
  30. 8.5.5 Procter and Gamble Recent Developments
  31. 8.6 Reckitt Benckiser Group
  32. 8.6.1 Reckitt Benckiser Group Company Information
  33. 8.6.2 Reckitt Benckiser Group Business Overview
  34. 8.6.3 Reckitt Benckiser Group OTC Cough and Cold and Allergy Medicine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Reckitt Benckiser Group OTC Cough and Cold and Allergy Medicine Product Portfolio
  36. 8.6.5 Reckitt Benckiser Group Recent Developments
  37. 8.7 Sanofi-Aventis
  38. 8.7.1 Sanofi-Aventis Company Information
  39. 8.7.2 Sanofi-Aventis Business Overview
  40. 8.7.3 Sanofi-Aventis OTC Cough and Cold and Allergy Medicine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi-Aventis OTC Cough and Cold and Allergy Medicine Product Portfolio
  42. 8.7.5 Sanofi-Aventis Recent Developments
  43. 8.8 GlaxoSmithKline
  44. 8.8.1 GlaxoSmithKline Company Information
  45. 8.8.2 GlaxoSmithKline Business Overview
  46. 8.8.3 GlaxoSmithKline OTC Cough and Cold and Allergy Medicine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GlaxoSmithKline OTC Cough and Cold and Allergy Medicine Product Portfolio
  48. 8.8.5 GlaxoSmithKline Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer OTC Cough and Cold and Allergy Medicine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer OTC Cough and Cold and Allergy Medicine Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Merck and Co.
  56. 8.10.1 Merck and Co. Company Information
  57. 8.10.2 Merck and Co. Business Overview
  58. 8.10.3 Merck and Co. OTC Cough and Cold and Allergy Medicine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Merck and Co. OTC Cough and Cold and Allergy Medicine Product Portfolio
  60. 8.10.5 Merck and Co. Recent Developments
  61. 8.11 Novartis
  62. 8.11.1 Novartis Company Information
  63. 8.11.2 Novartis Business Overview
  64. 8.11.3 Novartis OTC Cough and Cold and Allergy Medicine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Novartis OTC Cough and Cold and Allergy Medicine Product Portfolio
  66. 8.11.5 Novartis Recent Developments
  67. 8.12 Johnson and Johnson
  68. 8.12.1 Johnson and Johnson Company Information
  69. 8.12.2 Johnson and Johnson Business Overview
  70. 8.12.3 Johnson and Johnson OTC Cough and Cold and Allergy Medicine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Johnson and Johnson OTC Cough and Cold and Allergy Medicine Product Portfolio
  72. 8.12.5 Johnson and Johnson Recent Developments
  73. 8.13 Sun Pharmaceutical Industries
  74. 8.13.1 Sun Pharmaceutical Industries Company Information
  75. 8.13.2 Sun Pharmaceutical Industries Business Overview
  76. 8.13.3 Sun Pharmaceutical Industries OTC Cough and Cold and Allergy Medicine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sun Pharmaceutical Industries OTC Cough and Cold and Allergy Medicine Product Portfolio
  78. 8.13.5 Sun Pharmaceutical Industries Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 OTC Cough and Cold and Allergy Medicine Value Chain Analysis
  2. 9.1.1 OTC Cough and Cold and Allergy Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 OTC Cough and Cold and Allergy Medicine Sales Mode & Process
  6. 9.2 OTC Cough and Cold and Allergy Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 OTC Cough and Cold and Allergy Medicine Distributors
  9. 9.2.3 OTC Cough and Cold and Allergy Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst